Get the app
US › Healthcare

Enveric Biosciences Inc (ENVB)

US · Healthcare · Biotechnology

$1.38-0.72%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-3.0M
EPS
$-0.76

Key statistics

Market cap
$6.2M
Forward P/E
23.1
P/B
0.85
Book value
$2.05
EPS (TTM)
$-13.01
52-week high
$13.25
52-week low
$1.17
50-day MA
$1.47
200-day MA
$2.17
Beta
1.18

Analyst view

with an average price target of $10.00.

Shareholding

Insiders
8.89%
Institutions
12.02%

Largest institutional holders

FundStake
Sio Capital Management, LLC4.02%
Ikarian Capital, LLC2.23%
AdvisorShares Investments, LLC0.79%
Renaissance Technologies Corp0.72%
Armistice Capital, LLC0.71%
BOOTHBAY FUND MANAGEMENT, LLC0.67%
XTX Topco Ltd0.42%
HRT FINANCIAL LLC0.35%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Enveric Biosciences Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.